ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Stannsoporfin With Light Therapy for Newborn Babies With Jaundice

ClinicalTrials.gov ID: NCT01887327

Public ClinicalTrials.gov record NCT01887327. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 2:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b Multicenter, Single Dose, Randomized, Double Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of Two Doses of Stannsoporfin in Combination With Phototherapy in Neonates

Study identification

NCT ID
NCT01887327
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company
Industry
Enrollment
91 participants

Conditions and interventions

Interventions

  • Phototherapy Procedure
  • Placebo Drug
  • Stannsoporfin Drug

Procedure · Drug

Eligibility (public fields only)

Age range
1 Hour to 72 Hours
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 15, 2013
Primary completion
Mar 21, 2016
Completion
Mar 21, 2016
Last update posted
Feb 5, 2020

2013 – 2016

United States locations

U.S. sites
18
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
Arrowhead Regional Medical Center Colton California 92324
University of California San Diego Medical Center San Diego California 92103
University of CA, San Francisco San Francisco California 94145
Univ Florida Hospital Jacksonville Florida 32209
Kosair Children's Hospital Louisville Kentucky 40202
University of Louisville Hospital Louisville Kentucky 40202
Univ Med Ctr of Southern Nevada Las Vegas Nevada 89102
Rutgers University Hospital Newark New Jersey 07103
Winthrop University Hospital Mineola New York 11501
Stoney Brook Univ Hospital Stony Brook New York 22794
WakeMed Health and Hospitals Raleigh North Carolina 27610
Toledo Children's Hospital Toledo Ohio 43606
Hahnemann University Hospital/St. Christopher's Hospital for Children Philadelphia Pennsylvania 19102
Medical Univ of South Carolina Charleston South Carolina 29425
University of Tennessee Health Science Center Memphis Tennessee 38163
JPS Health Network Fort Worth Texas 76104
Univ Texas Medical Branch Galveston Texas 77555
Children's Hospital of Richmond at VCU Richmond Virginia 23298

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01887327, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 5, 2020 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01887327 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →